Cód QR

Combination chemotherapy with intermittent erlotinib and pemetrexed for pretreated patients with advanced non-small cell lung cancer: a phase I dose-finding study

<p>Abstract</p> <p>Background</p> <p>Erlotinib and pemetrexed have been approved for the second-line treatment of non-small cell lung cancer (NSCLC). These two agents have different mechanisms of action. Combined treatment with erlotinib and pemetrexed could potentially augment the antitumor activit...

Cur síos iomlán

Sábháilte in:
Príomhchruthaitheoirí: Minami Seigo, Kijima Takashi, Takahashi Ryo, Kida Hiroshi, Nakatani Takeshi, Hamaguchi Masanari, Takeuchi Yoshiko, Nagatomo Izumi, Yamamoto Suguru, Tachibana Isao, Komuta Kiyoshi, Kawase Ichiro
Formáid: Artigo
Teanga:Inglês
Foilsithe / Cruthaithe: BMC 2012-07-01
Sraith:BMC Cancer
Ábhair:
Combination
Erlotinib
Pemetrexed
NSCLC
Phase I
Rochtain ar líne:http://www.biomedcentral.com/1471-2407/12/296
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla